In vivo detection of inducible nitric oxide synthase in rodent gliomas

Free Radical Biology and Medicine

Volumn 48, Issue 5, 2010, Pages 691-703

  Towner, Rheal A ^a   Smith, Nataliya ^a   Doblas, Sabrina ^a   Garteiser, Philippe ^a   Watanabe, Yasuko ^a   He, Ting ^a   Saunders, Debra ^a   Herlea, Oana ^b   Silasi Mansat, Robert ^b   Lupu, Florea ^b  

^a Advanced Magnetic Resonance Center

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

C6; ENU; Free radicals; Glioma; In vivo; iNOS; Molecular MRI; RG2; Rodent

Indexed keywords

ALBUMIN; BIOTIN; INDUCIBLE NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; FEMALE; FLUORESCENCE IMAGING; GLIOMA; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MOLECULAR IMAGING; MOLECULAR PROBE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TRANSMISSION ELECTRON MICROSCOPY; TUMOR VASCULARIZATION; WESTERN BLOTTING;

ALBUMINS; ANIMALS; ANTIBODIES, MONOCLONAL; BRAIN NEOPLASMS; CELL LINE, TUMOR; ETHYLNITROSOUREA; FEMALE; FLUORESCENCE; GADOLINIUM DTPA; GLIOMA; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; MOLECULAR PROBE TECHNIQUES; NEOPLASM TRANSPLANTATION; NITRIC OXIDE SYNTHASE TYPE II; PREGNANCY; RATS; RATS, INBRED F344;

RATTUS; RODENTIA;

EID: 75149127633     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2009.12.012     Document Type: Article

References (59)

1. Palmer R.M., Ferrige A.G., and Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327 (1987) 524
2. Bredt D.S., and Snyder S.H. Nitric oxide: a physiologic messenger molecule. Annu. Rev. Biochem. 63 (1994) 175
3. Moncada S., Palmer R.M., and Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43 (1991) 109
4. Lala P.K., and Orucevic A. Role of nitric oxide in tumor progression: lessons from experimental tumors. Cancer Metastasis Rev 17 (1998) 91
5. Cobbs C.S., Brenman J.E., Aldape K.D., Bredt D.S., and Israel M.A. Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res. 55 (1995) 727
6. Floyd R.A., Kotake Y., Towner R.A., Guo W.-X., Nakae D., and Konishi Y. Nitric oxide and cancer development. J. Toxicol. Pathol. 20 (2007) 77-92
7. Legler J.M., Ries L.A., Smith M.A., Warren J.L., Heineman E.F., Kaplan R.S., and Linet M.S. Cancer surveillance series. Brain and other central nervous system cancers: recent trends in incidence and mortality. J. Natl. Cancer Inst. 91 (1999) 1382-1390
8. Central Brain Tumor Registry of the United States. Statistical report: primary brain tumors in the United States, 1995-1999 (2002), CBTRUS, Hinsdale, IL
9. Sanson M., Thillet J., and Hoang-Xuan K. Molecular changes in gliomas. Curr. Opin. Oncol. 16 (2004) 607-613
10. Demuth T., and Berens M.E. Molecular mechanisms of glioma cell migration and invasion. J. Neuro.-Oncol. 70 (2004) 217-228
11. Rao R.D., and James C.D. Altered molecular pathways in gliomas: an overview of clinically relevant issues. Semin. Oncol. 31 (2004) 595-604
12. Barth R.F. Rat brain tumor models in experimental neuro-oncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas. J. Neuro.-Oncol. 36 (1998) 91-102
13. Grobben B., De Deyn P.P., and Slegers H. Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion. Cell Tissue Res. 310 (2002) 257-270
14. Zhang X., Wu J., Gao D., Fei Z., Qu Y., and Jing J. Development of a rat C6 brain tumor model. Chin. Med. J. 115 (2002) 455-457
15. Aas A.T., Brun A., Blennow C., Stramblad S., and Salford L.G. The RG2 rat glioma model. J. Neuro.-Oncol. 23 (1995) 175-183
16. Kish P.E., Blaivas M., Strawderman M., Muraszko K.M., Ross D.A., Ross B.D., and McMahon G. MRI of ethyl-nitrosourea-induced rat gliomas: a model for experimental therapeutics of low-grade gliomas. J. Neuro.-Oncol. 53 (2001) 243-257
17. Omuro A.M.P., Leite C.C., Mokhtari K., and Delattre J.-Y. Pitfalls in the diagnosis of brain tumors. Lancet Neurol. 5 (2006) 937-948
18. Nelson A.L., Algon S.A., Munasinghe J., Graves O., Goumnervova L., Burstein D., Pomeroy S.L., and Kim J.Y. Magnetic resonance imaging of patched heterozygous and xenografted mouse brain tumors. J. Neurooncol. 62 (2003) 259-267
19. Taillander L., Antunes L., and Angioi-Duprez K.S. Models for neuro-oncological preclinical studies: solid orthotopic and heterotopic grafts of human gliomas into nude mice. J. Neurosci. Methods 125 (2003) 147-157
20. Schmidt K.F., Ziu M., Schmidt N.O., Vaghasia P., Cargioloi T.G., Doshi S., Albert M.S., Black P.M.L., Carroll R.S., and Sun Y. Volume reconstruction techniques improve the correlation between histological and in vivo tumor volume measurements in mouse models of human gliomas. J. Neuro.-Oncol. 68 (2004) 207-215
21. Badruddoja M.A., Krouwer H.G., Rand S.D., Rebro K.J., Pathak A.P., and Schmainda K.M. Antiangiogenic effects of dexamethasone in 9L gliosarcoma assessed by MRI cerebral blood volume maps. Neuro.-Oncol. 5 (2003) 235-243
22. Zhou R., Mazurchuk R., and Straubinger R.M. Antivascular effects of doxorubicin-containing liposomes in an intracranial rat brain tumor model. Cancer Res. 62 (2002) 2561-2566
23. Dafni H., Landsman L., Schechter B., Kohen F., and Neeman M. MRI and florescence microscopy of the acute vascular response to VEGF165: vasodilation, hyper-permeability and lymphatic uptake, followed by rapid inactivation of the growth factor. NMR Biomed. 15 (2002) 120-131
24. Towner R.A., Smith N., Doblas S., Tesiram Y., Saunders D., Cranford R., Silasi-Mansat R., Herlea O., and Lupu F. In vivo detection of c-Met expression in a rat C6 glioma model. J. Cell. Mol. Med. 12 (2008) 174-186
25. Hermanson G. Bioconjugate Techniques (1996), Academic Press, New York 176
26. Doblas S., Saunders D., Kshirsagar P., Pye Q., Oblander J., Gordon B., Kosanke S., Floyd R.A., and Towner R.A. Phenyl-tert-butyl nitrone induces tumor regression and decreases angiogenesis in a C6 rat glioma model. Free Radic. Biol. Med. 44 (2008) 63-72
27. Williams D.S., Detre J.A., Leigh J.S., and Koretsky A.P. Magnetic resonance imaging of perfusion using spin inversion of arterial water. Proc. Natl. Acad. Sci. USA 89 (1992) 212-216
28. Herscovitch P., and Raichle M.E. What is the correct value for the brain-blood partition coefficient for water?. J. Cereb. Blood Flow Metab. 5 (1985) 65-69
29. Lupu C., Westmuckett A.D., Peer G., Ivanciu L., Zhu H., Taylor Jr. F.B., and Lupu F. Tissue factor-dependent coagulation is preferentially up-regulated within arterial branching areas in a baboon model of Escherichia coli sepsis. Am. J. Pathol. 167 (2005) 1161-1172
30. Isakovic A., Harhaji L., Dacevic M., and Trajkovic V. Adenosine rescues glioma cells from cytokine-induced death by interfering with the signaling network involved in nitric oxide production. Eur. J. Pharmacol. 591 (2008) 106-113
31. Swaroop G.R., Malcolm G.P., Kelly P.A.T., Ritchie I., and Whittle I.R. Effects of nitric oxide modulation on tumor blood flow and microvascular permeability in C6 glioma. NeuroReport 9 (1998) 2577-2581
32. Swaroop G.R., Kelly P.A.T., Bell H.S., Shinoda J., Yamaguchi S., and Whittle I.R. The effects of chronic nitric oxide synthase suppression on glioma pathophysiology. Br. J. Neurosurg. 14 (2000) 543-548
33. Yamaguchi S., Bell H.S., Shinoda J., Holmes M.C., Wharton S.B., and Whittle I.R. Glioma tumourigenicity is decreased by iNOS knockout: experimental studies using the C6 striatal implantation glioma model. Br. J. Neurosurg. 16 (2002) 567-572
34. Shinoda J., McLaughlin K.E., Bell H.S., Swaroop G.R., Yamaguchi S., Holmes M.C., and Whittle I.R. Molecular mechanisms underlying dexamethasone inhibition of iNOS expression and activity in C6 glioma cells. Glia 42 (2003) 68-76
35. Xu W., Liu L.Z., Loizidou M., Ahmed M., and Charles I.G. The role of nitric oxide in cancer. Cancer Res. 12 (2002) 311-320
36. Panda K., Chawla-Sarkar M., Santos C., Koeck T., Erzurum S.C., Parkinson J.F., and Stuehr D.J. Visualizing inducible nitric-oxide synthase in living cells with a heme-binding fluorescent inhibitor. Proc. Natl. Acad. Sci. USA 102 (2005) 10117-10122
37. Lim M.H., Xu D., and Lippard S.J. Visualization of nitric oxide in living cells by a copper-based fluorescent probe. Nat. Chem. Biol 2 (2006) 375-380
38. Pustelny K., Bielanska J., Plonka P.M., Rosen G.M., and Elas M. In vivo spin trapping of nitric oxide from animal tumors. Nitric Oxide 16 (2007) 202-208
39. Li K.C.P., and Bednarski M.D. Vascular-targeted molecular imaging using functionalized polymerized vesicles. J. Magn. Reson. Imaging 16 (2002) 388-393
40. 3-targeted magnetic resonance imaging. Nat. Med. 4 (1998) 623-626
41. Konda S.D., Aref M., Wang S., Brechbiel M., and Wiener E.C. Specific targeting of folate-dendrimer MRI contrast agents to the high affinity folate receptor expressed in ovarian tumor xenografts. Magn. Reson. Mater. Phys. Biol. Med. 12 (2001) 104-113
42. Artemov D., Mori N., Ravi R., and Bhujwalla Z.M. Magnetic resonance molecular imaging of the HER-2/neu receptor. Cancer Res. 63 (2003) 2723-2727
43. Vera D.R., Buonocore M.H., Wisner E.R., Katzberg R.W., and Stadalnik R.C. A molecular receptor-binding contrast agent for magnetic resonance imaging of the liver. Acad. Radiol. 2 (1995) 497-506
44. Towner R.A., Smith N., Tesiram Y.A., Abbott A., Saunders D., Blindauer R., Herlea O., Silasi-Mansat R., and Lupu F. In vivo detection of c-Met expression in a rat hepatocarcinogenesis model using molecularly targeted magnetic resonance imaging. Mol. Imaging 6 (2007) 18-29
45. Schneider S.W., Ludwig T., Tatenhorst L., Braune S., Oberleithner H., Senner V., and Paulus W. Glioblastoma cells release factors that disrupt blood-brain barrier features. Acta Neuropathol. 107 (2004) 272-276
46. Lund C.V., Nguyen M.T., Owens G.C., Pakchoian A.J., Shaterian A., Kruse C.A., and Eliceiri B.P. Reduced glioma infiltration in Src-deficient mice. J. Neurooncol 78 (2006) 19-29
47. Cao Y., Tsien C.I., Shen Z., Tatro D.S., Ten Haken R., Kessler M.L., Chenevert T.L., and Lawrence T.S. Use of magnetic resonance imaging to assess blood-brain/blood-glioma barrier opening during conformal radiotherapy. J. Clin. Oncol. 23 (2005) 4127-4136
48. Eissa N.T., Haggerty C.M., Palmer C.D., Patton W., and Moss J. Identification of residues critical for enzymatic activity in the domain encoded by exons 8 and 9 of the human inducible nitric oxide synthase. Am. J. Respir. Cell Mol. Biol. 24 (2001) 616-620
49. Stolz D.B., Zamora R., Vodovotz Y., Loughran P.A., Billiar T.R., Kim Y.-M., Simmons R.L., and Watkins S.C. Peroxisomal localization of inducible nitric oxide synthase in hepatocytes. Hepatology 36 (2002) 81-93
50. Loughran P.A., Stolz D.B., Vodovotz Y., Watkins S.C., Simmons R.L., and Billiar T.R. Monomeric inducible nitric oxide synthase localizes to peroxisomes in hepatocytes. Proc. Natl. Acad. Sci. USA 102 (2005) 13837-13842
51. Vodovotz Y., Russell D., Xie Q.-w., Bogdan C., and Nathan C. Vesicle membrane association of nitric oxide synthase in primary mouse macrophages. J. Immunol. 154 (1995) 2914-2925
52. Collins J.L., Vodovotz Y., Hierholzer C., Villavicencio R.T., Liu S., Alber S., Gallo D., Stolz D.B., Watkins S.C., Godfrey A., Gooding W., Kelly E., Peitzman A.B., and Billiar T.R. Characterization of the expression of inducible nitric oxide synthase in rat and human liver during hemorrhagic shock. Shock 19 (2003) 117-122
53. Oyoshi T., Nomoto M., Hirano H., and Kuratsu J.-i. Pathodynamics of nitric oxide production within implanted glioma studied within an in vivo microdialysis technique and immunohistochemistry. J. Pharmacol. Sci. 91 (2003) 15-22
54. Hakyemez B., Erdogan C., Ercan I., Ergin N., Uysal S., and Atahan S. High-grade and low-grade gliomas: differentiation by using perfusion MR imaging. Clin. Radiol. 60 (2005) 493-502
55. Adzamli K., Yablonskiy D.A., Chicoine M.R., Won E.K., Galen K.P., Zahner M.C., Woolsey T.A., and Ackerman J.J. Albumin-binding MR blood pool agents as MRI contrast agents in an intracerebral mouse glioma model. Magn. Reson. Med. 49 (2003) 586-590
56. Gudinaviciene I., Pranys D., and Juozaityte E. Impact of morphology and biology on the prognosis of patients with gliomas. Medicina 40 (2004) 112-120
57. Liu Y., Hashizume K., Chen Z., Samoto K., Ningaraj N., Asotra K., and Black K.L. Correlation between bradykinin-induced blood-tumor barrier permeability and B2 receptor expression in experimental brain tumors. Neurol. Res. 23 (2001) 379-387
58. Giannopoulou E., Ravazoula P., Kalofonos H., Makatsoris T., and Kardamakis D. Expression of HIF-1alpha and iNOS in astrocytic gliomas: a clinicopathological study. In Vivo 20 (2006) 421-425
59. Badn W., Visse E., Darabi A., Smith K.E., Salford L.G., and Siesjö P. Postimmunization with IFN-γ-secreting glioma cells combined with the inducible nitric oxide synthase inhibitor mercaptoethylguanidine prolongs survival of rats with intracerebral tumors. J. Immunol. 179 (2007) 4231-4238